An interdisciplinary team of Stanford researchers have developed MagSweeper, a patented robotic liquid biopsy device that efficiently isolates and purifies live CTCs (circulating tumor cells) from blood while removing 100% of contaminating blood cells.
Stanford researchers have developed a simple and effective method to sort semiconducting from metallic single walled carbon nanotubes (SWNT). This scalable technique uses semiconducting polymers to wrap around individual semiconducting SWNTs dispersed in a solution.
Researchers in Dr. Leonore Herzenberg's lab at Stanford have developed this technology and another (see Stanford Docket S15-009) to improve the ease and accuracy of flow cytometry experiments.
Stanford researchers successfully purified highly enriched semiconducting single-walled carbon nanotubes (SWNT) free of any dispersing agent via an easy, fast and scalable method.
Researchers in Dr. Leonore Herzenberg's lab at Stanford University have developed a portfolio of data management, storage, and analysis technologies that may be used for large data sets.
Researchers in Dr. Karl Deisseroth's lab have engineered a channelrhodopsin variant that can be stimulated by red light and has fast stimulation frequencies. In neurons, channelrhodopsins are light activated protein channels that induce action potential firing.
Circulating levels of Neuromedin U (NMU) peptide are correlated with insulin resistance and obesity and dynamically regulated to suppress insulin secretion.
Researchers in Prof. Gerald Crabtree's laboratory have produced a mouse allowing high-throughput screening for activity and inhibition of virtually any chromatin modifier in any murine tissue.
Stanford researchers have developed an R-spondin1-producing cell line. The cell line is a transfectant of 293T cells expressing mouse R-spondin1 protein tagged with N-terminus HA and C-terminus Fc.
Researchers in Prof. Michelle Monje-Deisseroth's laboratory have discovered a previously unknown mechanism for glioma tumor growth and invasion that defines a novel set of therapeutic targets.
Dr. Helen Blau and colleagues have developed a mouse model that recapitulates both the skeletal muscle and cardiac pathology seen in Duchenne Muscular Dystrophy (DMD) patients.
Stanford researchers have developed a cell line (MFB-F11) that can be used for an easy, sensitive, and specific bioassay to study the biological functions of Transforming Growth Factor-beta (TGF-beta).
Researchers in Dr. Dean Felsher's lab have generated a murine hepatocellular carcinoma (HCC) cell line with controllable MYC expression. HCC is one of the most common and incurable malignancies.
Dr. Rosemarie DeKruyff and colleagues have generated an agonistic TIM-1 monoclonal antibody (mAb), called TIM-1 mAb 3B3. TIM-1 plays critical roles in regulating immune cell activity and is also involved in allergic response and asthma.